Vision in depressive disorder

References

• Ainsworth K, Smith SE, Sharp T. Repeated administration of fluoxetine desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat. J Psychopharmacol 1998; 12: 252–257
   PubMedGoogle Scholar
• Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. [Review, 68 refs]. Trends Neurosci 1990; 13: 296–302
   PubMed Web of Science ®Google Scholar
• Bodis-Wollner I. Vision and neurodegenerative diseases. Vision Res 1997; 37: 3441–3443
   PubMedGoogle Scholar
• Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987; 110: 1675–1698
   PubMed Web of Science ®Google Scholar
• Brandstadter D, Oertel WH. Depression in Parkinson's disease. Review. Adv Neurol 2003; 91: 371–381
   PubMedGoogle Scholar
• Chen Y, Levy DL, Sheremata S, Nakayama K, Matthysse S, Holzman PS. Effects of typical atypical and no antipsychotic drugs on visual contrast detection in schizophrenia. Am J Psychiatry 2003; 160: 1795–1801
   PubMed Web of Science ®Google Scholar
• Delgado PL. Depression: the case for a monoamine deficiency. . [Review]. J Clin Psychiatry 2000; 61(Suppl 6)7–11
   PubMed Web of Science ®Google Scholar
• Di Matteo V, Di Mascio M, Di Giovanni G, Esposito E. Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors. Psychopharmacology 2000; 150: 45–51
   PubMed Web of Science ®Google Scholar
• Ebert D, Berger M. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. [Review]. Psychopharmacology 1998; 140: 1–10
   PubMed Web of Science ®Google Scholar
• Ebert D, Lammers CH. The central dopaminergic system and depression. [Review; German]. Nervenarzt 1997; 68: 545–555
   PubMedGoogle Scholar
• Foley JM, Legge GE. Contrast detection and near-threshold discrimination in human vision. Vision Res 1981; 21: 1041–1053
   PubMed Web of Science ®Google Scholar
• Frederick JM, Rayborn ME, Laties AM, Lam DM, Hollyfield JG. Dopaminergic neurons in the human retina. J Comparative Neurol 1982; 210: 65–79
   PubMed Web of Science ®Google Scholar
• Friberg TR, Borrero G. Diminished perception of ambient light: a symptom of clinical depression?. J Affect Disord 2000; 61: 113–118
   PubMed Web of Science ®Google Scholar
• Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA. The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ann Neurol 1989; 25: 357–364
   PubMedGoogle Scholar
• Green DM, Swets JA. Signal detection theory and psychophysics. Wiley, New York 1966
   Google Scholar
• Greenlee MW, Magnussen S. Limited-capacity mechanisms of visual discrimination. Vision Res 1998; 38: 375–385
   PubMed Web of Science ®Google Scholar
• Lambert G, Johansson M, Agren H, Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 2000; 57: 787–793
   PubMed Web of Science ®Google Scholar
• Lammers CH, Diaz J, Schwartz JC, Sokoloff P. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol Psychiatry 2000; 5: 378–388
   PubMed Web of Science ®Google Scholar
• Langheinrich T, Tebartz van Elst L, et al. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms visually evoked potentials and psychophysics. Clin Neurophysiol 2000; 111: 66–74
   PubMed Web of Science ®Google Scholar
• Larisch R, Klimke A, Vosberg H, Loffler S, Gaebel W, Muller-Gartner HW. In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression. NeuroImage 1997; 5: 251–260
   PubMedGoogle Scholar
• Lee B, Harris J. Contrast transfer characteristics of visual short-term memory. Vision Res 1996; 36: 2159–2166
   PubMedGoogle Scholar
• Leinhaas MA, Hedstrom NJ. Low vision: how to assess and treat its emotional impact. Geriatrics 1994; 49: 53–56
   PubMed Web of Science ®Google Scholar
• Lemke MR. Motor signs of depression. [Review, German]. Nervenarzt 1999; 70: 600–612
   PubMedGoogle Scholar
• Lieb K, Brucker S, Bach M, Els T, Lucking CH, Greenlee MW. Impairment in preattentive visual processing in patients with Parkinson's disease. Brain 1999; 122: 303–313
   PubMed Web of Science ®Google Scholar
• Liebermann HR, Pentland AP. Microcomputerbased estimation of psychophysical thresholds: The Best-Pest. Behav Res Methods Instrum 2003; 14: 21–25
   Google Scholar
• Magnussen S, Greenlee MW. The psychophysics of perceptual memory. Psychol Res 1999; 62: 81–92
   PubMed Web of Science ®Google Scholar
• Mai J. Behavioral effects of antidepressant drugs given repeatedly on the dopaminergic system. Dopamine and mental depression. Serra Pergamon, Oxford 1990; 139–146
   Google Scholar
• Masson G, Mestre D, Blin O. Dopaminergic modulation of visual sensitivity in man. [Review]. Fundam Clin Pharmacol 1993; 7: 449–463
   PubMed Web of Science ®Google Scholar
• Mestre D, Blin O, Serratrice G, Pailhous J. Spatiotemporal contrast sensitivity differs in normal aging and Parkinson's disease. Neurology 1990; 40: 1710–1714
   PubMed Web of Science ®Google Scholar
• Northoff G, Demisch L, Wenke J, Pflug B. Plasma homovanillic acid concentrations in catatonia. Biol Psychiatry 1996; 39: 436–443
   PubMedGoogle Scholar
• Palmer J. Attentional limits on the perception and memory of visual information. J Exp Psychol: Hum Percept Perform 1990; 16: 332–350
   PubMed Web of Science ®Google Scholar
• Praag HM, Korf J, Lakke JPWF, Schut T. Dopamine metabolism in depressions psychoses and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders. Psychol Med 1975; 5: 138–146
   PubMed Web of Science ®Google Scholar
• Randrup, A, Munkvad, I, Fog, R. 1975. Current developments in psychopharmacology. New York, 207–229.
   Google Scholar
• Ravnkilde B, Videbech P, Clemmensen K, Egander A, Rasmussen NA, Rosenberg R. Cognitive deficits in major depression. Scand J Psychol 2002; 43: 239–251
   PubMed Web of Science ®Google Scholar
• Scheibel AB. The thalamus and neuropsychiatric illness. J Neuropsychiatry Clin Neurosci 1997; 9: 342–353
   PubMedGoogle Scholar
• Tebartz van Elst L, Greenlee MW, Foley JM, Lücking CH. Contrast detection discrimination and adaptation in patients with Parkinson's disease and multiple system atrophy. Brain 1997; 120: 2219–2228
   PubMedGoogle Scholar
• Treutwein B. Adaptive psychophysical procedures. Vision Res 1995; 35(17)2503–2522
   PubMed Web of Science ®Google Scholar
• Ventura R, Cabib S, Puglisi-Allegra S. Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral ‘despair’ in a mouse model of depression. Neuroscience 2002; 115: 999–1007
   PubMedGoogle Scholar
• Wells BG, Marken PA. Bromocriptine in treatment of depression. DICP: The Annals of Pharmacotherapy 1989; 23: 600–602
   PubMedGoogle Scholar
• Wickens TD. Elementary signal detection theory. Oxford University Press, Oxford 2001
   Google Scholar
• Willner P. Dopamine and depression: a review of recent evidence. I–III. [Review, 162 refs]. Brain Res 1983; 287: 211–246
   PubMedGoogle Scholar
• Willner, P. 1995. Dopaminergic mechanisms in depression and mania. In:. K Bloom, New York, Raven Press. 921–932.
   Google Scholar
• Yamamoto M. Depression in Parkinson's disease: its prevalence diagnosis and neurochemical background. [Review]. J Neurol 2001; 248(Suppl 3)I5–11
   Google Scholar
• Zhou FM, Liang Y, Salas R, Zhang L, De Biasi M, Dani JA. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 2005; 46: 65–74
   PubMed Web of Science ®Google Scholar